Verginadis, Ioannis I.
Avgousti, Harris
Monslow, James
Skoufos, Giorgos http://orcid.org/0000-0001-9022-6334
Chinga, Frank
Kim, Kyle
Leli, Nektaria Maria
Karagounis, Ilias V.
Bell, Brett I. http://orcid.org/0000-0002-8439-1402
Velalopoulou, Anastasia
Salinas, Carlo Salas
Wu, Victoria S.
Li, Yang
Ye, Jiangbin http://orcid.org/0000-0003-1117-4869
Scott, David A. http://orcid.org/0000-0002-8668-2449
Osterman, Andrei L.
Sengupta, Arjun
Weljie, Aalim
Huang, Menggui http://orcid.org/0000-0002-4942-5558
Zhang, Duo http://orcid.org/0000-0003-3215-2466
Fan, Yi
Radaelli, Enrico http://orcid.org/0000-0002-2885-0221
Tobias, John W.
Rambow, Florian
Karras, Panagiotis http://orcid.org/0000-0002-7642-0875
Marine, Jean-Christophe http://orcid.org/0000-0003-2433-9837
Xu, Xiaowei
Hatzigeorgiou, Artemis G.
Ryeom, Sandra http://orcid.org/0000-0002-9869-4455
Diehl, J. Alan http://orcid.org/0000-0001-9854-5049
Fuchs, Serge Y. http://orcid.org/0000-0002-0136-5103
Puré, Ellen
Koumenis, Constantinos http://orcid.org/0000-0001-5945-4726
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001878)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5R25-CA140116-10, 5R25-CA140116-10, P01 CA217805, P01 CA165997, P01 CA128814, 1R01CA268597)
Ministry of Education and Religious Affairs, Sport and Culture (MIS-5000432, 2563)
American Cancer Society (RSG-20-036-01)
Article History
Received: 17 April 2021
Accepted: 20 April 2022
First Online: 2 June 2022
Competing interests
: C.K. is the scientific founder and holds equity position in Veltion Therapeutics. The remaining authors declare no competing interests.